You have 9 free searches left this month | for more free features.

Quadruple combination antidiabetic drugs

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diabetes, Type 2 Trial (Empagliflozin 25 MG, INS)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Empagliflozin 25 MG
  • INS
  • (no location specified)
Jul 19, 2022

Type 2 Diabetes Trial in Seoul (TZD group, SGLT-2 group)

Completed
  • Type 2 Diabetes Mellitus
  • TZD group
  • SGLT-2 group
  • Seoul, Korea, Republic of
    Division of Endocrinology and Metabolism, Department of Internal
May 3, 2021

Novel Antidiabetic Drug Combined With Angiotensin

Recruiting
  • Type 2 Diabetes
  • Antidiabetic Drugs
    • Beijing, Beijing, China
    • +1 more
    Jun 20, 2023

    Dipeptidyl-4 Inhibitors in Reducing Stroke Severity, From HIRA

    Not yet recruiting
    • Cerebral Infarction
    • +2 more
    • Dipeptidyl peptidase-4 inhibitor
    • (no location specified)
    Apr 5, 2023

    Type 2 Diabetes Trial in China, Korea, Republic of, United States (Efpeglenatide SAR439977, Placebo, Background therapy)

    Terminated
    • Type 2 Diabetes Mellitus
    • Efpeglenatide SAR439977
    • +2 more
    • Birmingham, Alabama
    • +46 more
    Nov 4, 2021

    Diabetic Patients, Type II Diabetes Trial in Sevilla (OA-enriched functional olive oil, commercial olive oil)

    Recruiting
    • Diabetic Patients
    • Type II Diabetes Mellitus
    • OA-enriched functional olive oil
    • commercial olive oil
    • Sevilla, Andalicía, Spain
      Virgen del Rocío University Hospital
    Sep 1, 2023

    H.Pylori Infection Trial in Beijing (Rifasutenizol capsules, Rabeprazole sodium enteric-coated tablets, Amoxicillin Capsules)

    Not yet recruiting
    • H.Pylori Infection
    • Rifasutenizol capsules
    • +7 more
    • Beijing, China
      Peking University Third Hospital
    May 3, 2023

    Hypertension Trial in Bloomingdale, Chicago (QUARTET LDQT, Candesartan)

    Active, not recruiting
    • Hypertension
    • Bloomingdale, Illinois
    • +1 more
    Aug 31, 2022

    Efficacy and Safety of Chiglitazar Sodium in the Treatment of T2DM Patients, Metformin Combined With Insulin Glargine in the

    Not yet recruiting
    • Efficacy and Safety of Chiglitazar Sodium in the Treatment of T2DM Patients
    • +6 more
    • Chiglitazar sodium
    • Chiglitazar placebo
    • Guangzhou, Guangdong, China
      the First Affiliated Hospital of Sun Yat-sen University
    Aug 17, 2023

    s and Activity Data in Type 2 Diabetes on Different Treatments

    Not yet recruiting
    • Diabetes Mellitus, Type 2
    • Lifestyle
    • +4 more
    • (no location specified)
    Sep 16, 2022

    Hypertension Trial in Brazil (candesartan cilexetil + chlorthalidone + amlodipine, Exforge HCT® (valsartan 160mg +

    Not yet recruiting
    • Hypertension
    • candesartan cilexetil + chlorthalidone + amlodipine
    • Exforge HCT® (valsartan 160mg + hydrochlorothiazide 12.5mg + amlodipine 5mg)
    • Rio Branco, AC, Brazil
    • +21 more
    Jun 26, 2023

    Type 2 Diabetes Trial (INS068 injection, Insulin Glargine)

    Not yet recruiting
    • Type 2 Diabetes
    • INS068 injection
    • Insulin Glargine
    • (no location specified)
    Jan 17, 2023

    Helicobacter Pylori Eradication Trial in Kaohsiung (esomeprazole, tripotassium dicitrate bismuthate, tetracycline and

    Recruiting
    • Helicobacter Pylori Eradication
    • esomeprazole, tripotassium dicitrate bismuthate, tetracycline and levofloxacin
    • +2 more
    • Kaohsiung, Taiwan
      Kaohsiung Medical University Hospital
    Apr 28, 2023

    Diabetes, Stroke Trial in Chiayi City (Metformin plus Pioglitazone plus an SGLT2 inhibitor)

    Recruiting
    • Diabetes Mellitus
    • Stroke
    • Metformin plus Pioglitazone plus an SGLT2 inhibitor
    • Chiayi City, Taiwan
      Chang Gung Memorial Hospital, Chiayi Branch
    Jan 11, 2022

    Semaglutide in Type 2 Diabetes - A Cohort Study Based on Nordic

    Enrolling by invitation
    • Diabetes Mellitus, Type 2
    • Odense, Denmark
      Novo Nordisk Investigational Site
    Nov 30, 2022

    Optimized Diagnosis and Precision Medicine of MODY

    Recruiting
    • Maturity-Onset Diabetes of the Young (MODY)
    • +2 more
      • Taichung, Taiwan
        Taichung veterans general hospital
      Oct 26, 2023

      Diabetes Trial in Minya (MorDom)

      Recruiting
      • Diabetes
      • MorDom
      • Minya, Egypt
        Soad A. Mohamad
      Jun 1, 2023

      Hypertension, Arterial Hypertension Trial in Changsha (Quadruple combination of half doses therapy?Dual combination of standard

      Recruiting
      • Hypertension
      • Arterial Hypertension
      • Quadruple combination of half doses therapy→Dual combination of standard dose therapy
      • Dual combination of standard dose therapy→ Quadruple combination of half doses therapy
      • Changsha, Hunan, China
        The Third Xiangya Hospital of Central South University
      Jul 13, 2022

      Helicobacter Pylori Infection Trial in Shanghai (Esomeprazole, Bismuth Potassium Citrate, Tetracycline)

      Recruiting
      • Helicobacter Pylori Infection
      • Shanghai, Shanghai, China
        Renji Hospital, School of Medicine, Shanghai Jiao Tong Universit
      May 16, 2023

      Helicobacter Pylori Infection Trial in Ljubljana (Bismuth Subcitrate)

      Recruiting
      • Helicobacter Pylori Infection
      • Bismuth Subcitrate
      • Ljubljana, Slovenia
        Matjaž Homan
      Nov 19, 2023

      Endothelial Dysfunction, Diabetes, Type 1, Biomarkers Trial in Celje (Semaglutide Pen Injector [Ozempic], Empagliflozin 10 MG)

      Completed
      • Endothelial Dysfunction
      • +9 more
      • Semaglutide Pen Injector [Ozempic]
      • Empagliflozin 10 MG
      • Celje, Slovenia
        General Hospital Celje
      May 10, 2023

      Parkinson Disease, Neurodegenerative Diseases Trial in Karachi (conventional therapy, Saffron and Chamomile, Crocin and

      Recruiting
      • Parkinson Disease
      • Neurodegenerative Diseases
      • conventional therapy
      • +2 more
      • Karachi, Sindh, Pakistan
        Jinnah Postgraduate Medical Centre (JPMC),
      Jan 23, 2023

      Perioperative Pain Trial in Hackensack (Ibuprofen 600 mg, OxyCODONE 5 Mg Oral Capsule)

      Withdrawn
      • Perioperative Pain
      • Ibuprofen 600 mg
      • OxyCODONE 5 Mg Oral Capsule
      • Hackensack, New Jersey
        Hackensack University Medical Center
      Sep 7, 2022

      Helicobacter Pylori Infection Trial in Shanghai (Esomeprazole, Bismuth Potassium Citrate, Tetracycline,Metronidazole)

      Completed
      • Helicobacter Pylori Infection
      • Shanghai, Shanghai, China
        Renji Hospital, School of Medicine, Shanghai Jiao Tong Universit
      Nov 10, 2022

      Cognitive Protective Effect of Newer Antidiabetic Drugs

      Recruiting
      • Type 2 Diabetes
      • Alexandria, Egypt
        Alexandria University
      Jul 24, 2022